SHP2 Inhibitor Synthesis via B3′ Intermediate and Thiosulfate

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing synthesis methods for the compound (3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine require large quantities of materials and pose thermo safety risks, especially due to the use of excessive hydroxylamine hydrochloride and pyrophoric reagents like anhydrous Na2S.

Innovation Solution

A new synthesis route using a novel intermediate B3′ and sodium thiosulfate instead of sodium sulfide, along with optimized reaction conditions, reduces material requirements and eliminates thermo safety hazards, improving the efficiency and safety of the manufacturing process.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If equivalent amounts of lactone B2 are used to synthesize B3, then the reaction can proceed, but large quantities of material are required which is inefficient for commercial manufacture

Engineering Contradiction:
Improveamount of lactone B2 requiredVSAvoidmanufacturing efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent changes the stoichiometric parameters of the reaction by using a different synthetic route that requires only 0.5 equivalents of lactone B2 instead of 1 equivalent, thereby reducing material consumption while maintaining productivity

Inventive Principle:
Principle #35Parameter changes

2Reliability

If at least five fold molar excess of hydroxylamine hydrochloride is used to achieve good conversion from B3 to B4, then the reaction converts well, but this poses thermo safety risks for large scale synthesis

Engineering Contradiction:
Improveconversion efficiencyVSAvoidthermo safety risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and removes the problematic step requiring 5-fold excess of hydroxylamine hydrochloride by using an alternative synthetic route that avoids this high-risk condition while maintaining good conversion efficiency

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent converts the harmful thermo safety risk into a benefit by selecting a reaction pathway that inherently requires fewer reagents, thus transforming a potentially dangerous process into a safe one while maintaining or improving conversion efficiency

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Ease of manufacture

If anhydrous Na2S is used in the synthesis, then the reaction can proceed, but the reagent is pyrophoric and poses safety hazards

Engineering Contradiction:
Improvereaction feasibilityVSAvoidpyrophoricity
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the dangerous pyrophoric reagent anhydrous Na2S with sodium thiosulfate, which is safer, commercially available in large scale, and equally effective for the synthesis, eliminating the need to handle hazardous materials

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new method requires less material and safer reagents, enhancing the scalability and environmental friendliness of the synthesis, while maintaining the effectiveness of producing the compound for inhibiting SHP2 activity.

Implementation Method 1

reacting a compound of the formula V with sodium thiosulfate to yield the intermediate B3′

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 2

cyclized with hydroxylamine, or a salt thereof, to yield a hydroxylamine compound of the formula VII

Methodology Applied
Scientific EffectCyclization reaction: Chemical Bonding

Implementation Method 3

hydrogenated to yield an amino compound of the formula VIII

Methodology Applied
Scientific EffectHydrogenation: Hydrogenation

Data Source

PatentUS12441737B2Manufacture of compounds and compositions for inhibiting the activity of SHP2
Publication Date: 2025.10.14 NOVARTIS AG
  • US12441737B2 patent drawing
  • US12441737B2 patent drawing
  • US12441737B2 patent drawing

AI summary

The present invention relates to a method for the manufacture of a compound of Formula I or a pharmaceutically acceptable salt, acid co-crystal, hydrate or other solvate thereof, said method comprising reacting a compound of the formula II with a compound of the formula III according to the following reaction scheme: wherein LG, A, n, m and p are as defined in the Summary of the Invention, said manufacture including the manufacture and use of a compound of the formula VI; wherein R1 is a secondary amino protecting group and R5 is unsubstituted or substituted alkyl, unsubstituted or substituted cycloalkyl or unsubstituted or substituted aryl.